biopython-sequence-io
Veto GatesRequired pass for any deployment consideration
| Dimension | Result | Detail |
|---|---|---|
| Scientific Integrity | PASS | No scientific-integrity problem was surfaced because the package did not claim more than the available records, article text, or script evidence supported. |
| Practice Boundaries | PASS | Practice boundaries held because the package remained focused on Use Biopython to read/write/convert biological sequence files (FASTA/GenBank/FASTQ, etc.)... rather than overclaiming what the records supported. |
| Methodological Ground | PASS | The legacy review kept the package aligned with its named analysis library, data structure, or processing workflow. |
| Code Usability | PASS | Code usability passed because the package still exposed a reviewable execution surface for its documented workflow. |
Core Capability85 / 100 — 8 Categories
Medical TaskExecution Average: 86.6 / 100 — Assertions: 20/20 Passed
Converting between common sequence formats (e.g., FASTA ↔ GenBank,... remained tied to the documented analysis contract even when the preserved evidence centered on instructions instead of a full rerun.
The archived run treated Reading and writing sequence datasets for downstream pipelines... as a bounded analysis workflow rather than a purely narrative instruction path.
This edge case stayed within the packaged analysis boundary and kept a reviewable task contract.
Robust sequence I/O via Bio.SeqIO for parsing and writing... remained tied to the documented analysis contract even when the preserved evidence centered on instructions instead of a full rerun.
This stress case stayed within the packaged analysis boundary and kept a reviewable task contract.
Key Strengths
- Primary routing is Data Analysis with execution mode A
- Static quality score is 85/100 and dynamic average is 78.6/100
- Assertions and command execution outcomes are recorded per input for human review
- Execution verification summary: No script verification was applicable